81 FR 41317 - National Cancer Institute; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 81, Issue 122 (June 24, 2016)

Page Range		41317-41318
FR Document		2016-14922

Federal Register, Volume 81 Issue 122 (Friday, June 24, 2016)

[Federal Register Volume 81, Number 122 (Friday, June 24, 2016)]
[Notices]
[Pages 41317-41318]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-14922]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications/contract proposals and the 
discussions could disclose confidential trade secrets or commercial 
property such as patentable material, and personal information 
concerning individuals associated with the grant applications/contract 
proposals, the disclosure of which would constitute a clearly 
unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel HTLV.
    Date: July 15, 2016.
    Time: 11:30 a.m. to 3:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 3W032/034, Rockville, MD 20850 (Telephone 
Conference Call).
    Contact Person: Kenneth L. Bielat, Ph.D., Scientific Review 
Officer, Research and Technology and Contract Review Branch,

[[Page 41318]]

Division of Extramural Activities, National Cancer Institute, 9609 
Medical Center Drive, Room 7W244, Rockville, MD 20892-9750, 240-276-
6373, [email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; NCI Clinical R01 Review.
    Date: July 20, 2016.
    Time: 1:00 p.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 2W914, Rockville, MD 20850 (Telephone Conference 
Call).
    Contact Person: Majed M. Hamawy, Ph.D. Scientific Review 
Officer, Research Programs Review Branch, Division of Extramural 
Activities, National Cancer Institute, 9609 Medical Center Drive, 
Room 7W120, Rockville, MD 20892-9750, 240-276-6457, [email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; EDRN.
    Date: July 21-22, 2016.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hilton Washington DC/Rockville, 1750 Rockville Pike, 
Rockville, MD 20852.
    Contact Person: Peter J. Wirth, Ph.D., Scientific Review 
Officer, Division of Extramural Activities, National Cancer 
Institute, 9609 Medical Center Drive, Room 7W514, Rockville, MD 
20892-9750, 240-276-6434, [email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Utilizing the PLCO Biospecimens Resource to Bridge Gaps in 
Cancer Etiology and Early Detection Research (U01).
    Date: July 28, 2016.
    Time: 11:00 a.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 2W030, Rockville, MD 20850 (Telephone Conference 
Call).
    Contact Person: Jeffrey E. DeClue, Ph.D., Scientific Review 
Officer, Research Technology and Contract Review Branch, Division of 
Extramural Activities, National Cancer Institute, 9609 Medical 
Center Drive, Room 7W238, Rockville, MD 20892-9750, 240-276-6371, 
[email protected].

    Name of Committee: National Cancer Institute Initial Review 
Group Subcommittee A--Cancer Centers.
    Date: August 11, 2016.
    Time: 8:00 a.m. to 4:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda North Marriott Hotel & Conference Center, 5701 
Marinelli Road, North Bethesda, MD 20852.
    Contact Person: Shamala K. Srinivas, Ph.D., Associate Director 
Office of Referral, Review, and Program Coordination, Division of 
Extramural Activities, National Cancer Institute, 9609 Medical 
Center Drive, Room 7W530, Rockville, MD 20892-9750, 240-276-6442, 
[email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: June 20, 2016.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-14922 Filed 6-23-16; 8:45 am]
 BILLING CODE 4140-01-P

Federal Register / Vol. 81, No. 122 / Friday, June 24, 2016 / Notices 41317

300aa–19, as added by Pub. L. 99–660 the ACCV includes the areas of subject a copy of his/her curriculum vitae; and
and amended, HRSA is requesting matter expertise noted above. As (3) the name, address, daytime
nominations for voting members of the indicated above, at least two of the three telephone number, and email address at
ACCV. ACCV members of the general public which the nominator can be contacted.
The ACCV advises the Secretary on must be legal representatives (parents or Nomination packages will be collected
the implementation of the VICP. Other guardians) of children who have and retained to create a pool of possible
activities of the ACCV include: suffered a vaccine-related injury or future ACCV voting members. When a
Recommending changes in the Vaccine death. Because those members must be vacancy occurs, nomination packages
Injury Table, at its own initiative or as the legal representatives of children from the appropriate category will be
the result of the filing of a petition; who have suffered a vaccine-related reviewed and nominees may be
advising the Secretary in implementing injury or death, to be considered for contacted.
section 2127 of the Act regarding the appointment to the ACCV in that HHS strives to ensure that the
need for childhood vaccination category there must have been a finding membership of the HHS Federal
products that result in fewer or no (i.e., a decision) by the U.S. Court of Advisory Committee is fairly balanced
significant adverse reactions; surveying Federal Claims or a civil court that a in terms of points of view represented
federal, state, and local programs and VICP-covered vaccine caused, or was and the committee’s function.
activities related to gathering presumed to have caused, the Appointment to the ACCV shall be
information on injuries associated with represented child’s injury or death. made without discrimination on basis of
the administration of childhood Based on a recommendation made by age, race, ethnicity, gender, sexual
vaccines, including the adverse reaction the ACCV, the Secretary will consider orientation, disability, and cultural,
reporting requirements of section having a health professional with religious, or socioeconomic status. The
2125(b) of the Act; advising the expertise in obstetrics as one of the Department encourages nominations of
Secretary on the methods of obtaining, members of the general public. qualified candidates from all groups and
compiling, publishing, and using ACCV members are appointed as locations.
credible data related to the frequency Special Government Employees. As
and severity of adverse reactions such, they are covered by the federal Jason E. Bennett,
associated with childhood vaccines; ethics rules, including the criminal Director, Division of the Executive Secretariat.
consulting on the development or conflict of interest statutes governing [FR Doc. 2016–14960 Filed 6–23–16; 8:45 am]
revision of Vaccine Information executive branch employees. For BILLING CODE 4165–15–P
Statements; and recommending to the example, an ACCV member may be
Director of the National Vaccine prohibited from discussions about
Program research related to vaccine making changes to the Vaccine Injury DEPARTMENT OF HEALTH AND
injuries which should be conducted to Table and Vaccine Information HUMAN SERVICES
carry out the VICP. Statements for the Hepatitis B vaccine if
The ACCV consists of nine voting he/she or his/her spouse owns stock National Institutes of Health
members appointed by the Secretary as valued above a certain amount in National Cancer Institute; Notice of
follows: (1) Three health professionals, companies which manufacturer this Closed Meetings
who are not employees of the United vaccine, affecting their own pecuniary
States Government, and who have interests—including interests imputed Pursuant to section 10(d) of the
expertise in the health care of children, to them. To evaluate possible conflicts Federal Advisory Committee Act, as
the epidemiology, etiology, and of interest, potential candidates will be amended (5 U.S.C. App.), notice is
prevention of childhood diseases, and asked to fill out the Confidential hereby given of the following meetings.
the adverse reactions associated with Financial Disclosure Report, OGE Form The meetings will be closed to the
vaccines, of whom at least two shall be 450, to provide detailed information public in accordance with the
pediatricians; (2) three members from concerning financial interests, provisions set forth in sections
the general public, of whom at least two consultancies, research grants, and/or 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
shall be legal representatives (parents or contracts that might be affected by as amended. The grant applications/
guardians) of children who have recommendations made by the ACCV. contract proposals and the discussions
suffered a vaccine-related injury or Interested persons may nominate one could disclose confidential trade secrets
death; and (3) three attorneys, of whom or more qualified persons for or commercial property such as
at least one shall be an attorney whose membership on the ACCV. Nominations patentable material, and personal
specialty includes representation of shall state that the nominee is willing to information concerning individuals
persons who have suffered a vaccine- serve as a member of the ACCV. associated with the grant applications/
related injury or death, and of whom Nominees will be invited to serve a 3- contract proposals, the disclosure of
one shall be an attorney whose specialty year term beginning the date of which would constitute a clearly
includes representation of vaccine appointment. A nomination package unwarranted invasion of personal
manufacturers. In addition, the Director should be submitted as hard copy, email privacy.
of the National Institutes of Health, the communication, or compact disk. A Name of Committee: National Cancer
Assistant Secretary for Health, the nomination package should include the Institute Special Emphasis Panel HTLV.
Director of the Centers for Disease following information for each nominee: Date: July 15, 2016.
Control and Prevention, and the (1) A letter of nomination stating the Time: 11:30 a.m. to 3:00 p.m.
Commissioner of the Food and Drug name, affiliation, and contact Agenda: To review and evaluate contract
sradovich on DSK3GDR082PROD with NOTICES

Administration (or the designees of such information for the nominee, the basis proposals.
officials) serve as nonvoting ex officio for the nomination (i.e., what specific Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
members. attributes, perspectives, and/or skills
3W032/034, Rockville, MD 20850 (Telephone
The Department of Health and Human does the individual possess that would Conference Call).
Services (HHS or Department) will benefit the workings of the ACCV) and Contact Person: Kenneth L. Bielat, Ph.D.,
consider nominations of all qualified the nominee’s field(s) of expertise; (2) a Scientific Review Officer, Research and
individuals with a view to ensure that biographical sketch of the nominee and Technology and Contract Review Branch,

VerDate Sep<11>2014 17:43 Jun 23, 2016 Jkt 238001 PO 00000 Frm 00031 Fmt 4703 Sfmt 4703 E:\FR\FM\24JNN1.SGM 24JNN1

41318 Federal Register / Vol. 81, No. 122 / Friday, June 24, 2016 / Notices

Division of Extramural Activities, National 93.393, Cancer Cause and Prevention DEPARTMENT OF HEALTH AND
Cancer Institute, 9609 Medical Center Drive, Research; 93.394, Cancer Detection and HUMAN SERVICES
Room 7W244, Rockville, MD 20892–9750, Diagnosis Research; 93.395, Cancer
240–276–6373, bielatk@mail.nih.gov. Treatment Research; 93.396, Cancer Biology National Institutes of Health
Name of Committee: National Cancer Research; 93.397, Cancer Centers Support;
Institute Special Emphasis Panel; NCI 93.398, Cancer Research Manpower; 93.399, Center for Scientific Review; Notice of
Clinical R01 Review. Cancer Control, National Institutes of Health,
HHS)
Closed Meetings
Date: July 20, 2016.
Time: 1:00 p.m. to 5:00 p.m. Dated: June 20, 2016. Pursuant to section 10(d) of the
Agenda: To review and evaluate grant Melanie J. Gray, Federal Advisory Committee Act, as
applications. amended (5 U.S.C. App.), notice is
Place: National Cancer Institute Shady Program Analyst, Office of Federal Advisory
Committee Policy. hereby given of the following meetings.
Grove, 9609 Medical Center Drive, Room
The meetings will be closed to the
2W914, Rockville, MD 20850 (Telephone [FR Doc. 2016–14922 Filed 6–23–16; 8:45 am]
Conference Call). public in accordance with the
BILLING CODE 4140–01–P
Contact Person: Majed M. Hamawy, Ph.D. provisions set forth in sections
Scientific Review Officer, Research Programs 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
Review Branch, Division of Extramural DEPARTMENT OF HEALTH AND as amended. The grant applications and
Activities, National Cancer Institute, 9609 HUMAN SERVICES the discussions could disclose
Medical Center Drive, Room 7W120, confidential trade secrets or commercial
Rockville, MD 20892–9750, 240–276–6457, property such as patentable material,
National Institutes of Health
mh101v@nih.gov.
and personal information concerning
Name of Committee: National Cancer National Institute of Allergy and individuals associated with the grant
Institute Special Emphasis Panel; EDRN. Infectious Diseases; Notice of Closed applications, the disclosure of which
Date: July 21–22, 2016.
Meeting would constitute a clearly unwarranted
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant Pursuant to section 10(d) of the invasion of personal privacy.
applications. Federal Advisory Committee Act, as Name of Committee: Center for Scientific
Place: Hilton Washington DC/Rockville, Review Special Emphasis Panel; Small
amended (5 U.S.C. App.), notice is
1750 Rockville Pike, Rockville, MD 20852. Business: Dermatology, Rheumatology and
Contact Person: Peter J. Wirth, Ph.D., hereby given of the following meeting.
The meeting will be closed to the Inflammation.
Scientific Review Officer, Division of Date: July 12, 2016.
Extramural Activities, National Cancer public in accordance with the
Time: 8:00 a.m. to 4:00 p.m.
Institute, 9609 Medical Center Drive, Room provisions set forth in sections Agenda: To review and evaluate grant
7W514, Rockville, MD 20892–9750, 240– 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., applications.
276–6434, pw2q@nih.gov. as amended. The grant applications and Place: Residence Inn Bethesda, 7335
Name of Committee: National Cancer the discussions could disclose Wisconsin Avenue, Bethesda, MD 20814.
Institute Special Emphasis Panel; Utilizing confidential trade secrets or commercial Contact Person: Yanming Bi, Ph.D.,
the PLCO Biospecimens Resource to Bridge property such as patentable material, Scientific Review Officer, Center for
Gaps in Cancer Etiology and Early Detection and personal information concerning Scientific Review, National Institutes of
Research (U01). individuals associated with the grant Health, 6701 Rockledge Drive, Room 4214,
Date: July 28, 2016. MSC 7814, Bethesda, MD 20892, 301–451–
applications, the disclosure of which
Time: 11:00 a.m. to 3:00 p.m. 0996, ybi@csr.nih.gov.
Agenda: To review and evaluate grant would constitute a clearly unwarranted
Name of Committee: AIDS and Related
applications. invasion of personal privacy.
Research Integrated Review Group; AIDS
Place: National Cancer Institute Shady Name of Committee: National Institute of Clinical Studies and Epidemiology Study
Grove, 9609 Medical Center Drive, Room Allergy and Infectious Diseases Special Section.
2W030, Rockville, MD 20850 (Telephone Emphasis Panel; Rapid Assessment of Zika Date: July 13, 2016.
Conference Call). Virus (ZIKV) Complications (R21). Time: 8:00 a.m. to 6:00 p.m.
Contact Person: Jeffrey E. DeClue, Ph.D., Date: July 21–22, 2016. Agenda: To review and evaluate grant
Scientific Review Officer, Research Time: 9:00 a.m. to 5:00 p.m. applications.
Technology and Contract Review Branch, Agenda: To review and evaluate grant Place: The Fairmont Washington, DC, 2401
Division of Extramural Activities, National applications. M Street NW., Washington, DC 20037.
Cancer Institute, 9609 Medical Center Drive, Place: National Institutes of Health, 5601 Contact Person: Hilary D. Sigmon, Ph.D.,
Room 7W238, Rockville, MD 20892–9750, Fishers Lane, Rockville, MD 20892 Scientific Review Officer, Center for
240–276–6371, decluej@mail.nih.gov. (Telephone Conference Call). Scientific Review, National Institutes of
Name of Committee: National Cancer Contact Person: Brenda L. Fredericksen, Health, 6701 Rockledge Drive, Room 5222,
Institute Initial Review Group Subcommittee Ph.D., Scientific Review Officer, Scientific MSC 7852, Bethesda, MD 20892, (301) 357–
A—Cancer Centers. Review Program, Division of Extramural 9236, sigmonh@csr.nih.gov.
Date: August 11, 2016. Activities, Room # 3G22A, National Institutes
Name of Committee: Center for Scientific
Time: 8:00 a.m. to 4:30 p.m. of Health/NIAID, 5601 Fishers Lane, MSC
Review Special Emphasis Panel; US-China
Agenda: To review and evaluate grant 9823, Bethesda, MD 20892–9823, (240) 669–
Program for Collaborative Biomedical
applications. 5052, brenda.fredericksen@nih.gov.
Research.
Place: Bethesda North Marriott Hotel & (Catalogue of Federal Domestic Assistance Date: July 20–21, 2016.
Conference Center, 5701 Marinelli Road, Program Nos. 93.855, Allergy, Immunology, Time: 8:00 a.m. to 5:00 p.m.
North Bethesda, MD 20852. and Transplantation Research; 93.856, Agenda: To review and evaluate grant
Contact Person: Shamala K. Srinivas, Microbiology and Infectious Diseases applications.
sradovich on DSK3GDR082PROD with NOTICES

Ph.D., Associate Director Office of Referral, Research, National Institutes of Health, HHS) Place: Bethesda Marriott Suites, 6711
Review, and Program Coordination, Division Dated: June 20, 2016. Democracy Boulevard, Bethesda, MD 20817.
of Extramural Activities, National Cancer Contact Person: Marci Scidmore, Ph.D.,
Institute, 9609 Medical Center Drive, Room Natasha M. Copeland,
Scientific Review Officer, Center for
7W530, Rockville, MD 20892–9750, 240– Program Analyst, Office of Federal Advisory
Scientific Review, National Institutes of
276–6442, ss537t@nih.gov. Committee Policy.
Health, 6701 Rockledge Drive, Room 3192,
(Catalogue of Federal Domestic Assistance [FR Doc. 2016–14921 Filed 6–23–16; 8:45 am] MSC 7808, Bethesda, MD 20892, 301–435–
Program Nos. 93.392, Cancer Construction; BILLING CODE 4140–01–P 1149, marci.scidmore@nih.gov.

VerDate Sep<11>2014 17:43 Jun 23, 2016 Jkt 238001 PO 00000 Frm 00032 Fmt 4703 Sfmt 4703 E:\FR\FM\24JNN1.SGM 24JNN1

Document Created: 2016-06-24 00:52:54
Document Modified: 2016-06-24 00:52:54

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		July 15, 2016.
FR Citation		81 FR 41317

81 FR 41317 - National Cancer Institute; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICESNational Institutes of Health

Federal Register Volume 81, Issue 122 (June 24, 2016)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health